2.1. Study design
This protocol is extracted from research article:
The therapeutic effects of naringenin on bronchial pneumonia in children
Pharmacol Res Perspect, Jul 26, 2021; DOI: 10.1002/prp2.825

The current study was conducted as a randomized controlled trial to lessen the potential confounding effects. A total of 186 children with bronchial pneumonia who were hospitalized between June 2019 and June 2020 in Zibo Central Hospital were recruited in this trial. The trial protocol was approved by ethics committee of Zibo Central Hospital. All statutory guardians of the participants were required to sign informed written consent before the participants were randomly assigned into the clinical trial.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.